Abstract
Summary
Treatment with crystalline chymotrypsin did not influence the course of neoplastic disease in experimental animals or in fifteen selected cancer patients.
Get full access to this article
View all access options for this article.
You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026
Select search scope: search across all journals or within the current journal
Treatment with crystalline chymotrypsin did not influence the course of neoplastic disease in experimental animals or in fifteen selected cancer patients.
View all access options for this article.